Roche expands Boston presence with new research center — STAT News
In Boston, Roche is expanding its presence thanks to a new research center, STAT News reports. The publication was released on September 18, 2026, in the biotech newsletter The Readout.
Gene therapy and lung cancer risk
In the introduction to the edition, the authors said they were discussing the approval of the first gene therapy for Sanfilippo syndrome. The text also notes that efforts to develop such a therapy were written about as far back as 10 years ago.
More current news is available on the UA.News Telegram channel Telegram.
Other topics in the edition include a rare genetic variant associated with a sharply increased risk of lung cancer in people who do not smoke. The authors also announced hearings on the approval of a candidate for the position of head of the US Food and Drug Administration, FDA.
Other newsletter topics
The edition separately mentions news from Xenon Pharma, which the authors described as both positive and negative. The material was prepared by biotech correspondent Meghana Keshavan, senior biotech journalist Adam Feuerstein, and Washington correspondent Margaret Manto.
